Health Care & Life Sciences » Pharmaceuticals | Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
54,889.20
54,707.50
52,767.20
50,132.40
50,085.30
36,229.60
Total Accounts Receivable
4,530.40
5,504.70
6,077.10
7,330.10
8,395.10
7,844.20
Inventories
5,722.90
5,600.30
4,270.10
5,371.70
6,737.80
12,078.30
Other Current Assets
3,537.20
5,002.50
3,997.60
2,711.00
3,466.50
2,963.80
Total Current Assets
68,679.70
70,815.00
67,112.10
65,545.30
68,684.80
59,116
Net Property, Plant & Equipment
880.60
651.00
536.50
464.50
528.90
771.20
Intangible Assets
15,498.80
21,568.50
21,168.60
22,154.20
21,444.50
34,439.10
Other Assets
1,345.70
1,792.00
1,891.10
2,120.70
2,486.80
18,280.30
Total Assets
87,613.70
95,405.10
91,919.00
96,643.10
95,299.90
114,668.70
Accounts Payable
2,035.90
3,242.70
2,877.50
8,036.60
8,979.90
Other Current Liabilities
5,509.90
10,506.80
9,534.30
6,755.70
8,714.80
Total Current Liabilities
7,545.80
13,749.50
12,411.70
14,792.30
17,694.70
Long-Term Debt
-
-
1,700.00
4,100.00
9,800.00
Deferred Taxes
1,208.90
578.60
1,210.80
3,119.90
87.20
Other Liabilities
776.10
902.80
987.40
1,391.50
1,816.00
Total Liabilities
8,321.90
14,652.30
15,099.20
23,522.30
31,378.30
Common Equity (Total)
79,468.50
80,760.70
76,887.90
73,248.20
64,120.20
Total Shareholders' Equity
79,468.50
80,760.70
76,887.90
73,248.20
64,120.20
Total Equity
79,291.80
80,752.80
76,819.80
73,120.80
63,921.60
Liabilities & Shareholders' Equity
87,613.70
95,405.10
91,919.00
96,643.10
95,299.90
Accumulated Minority Interest
176.60
7.90
68.10
127.40
198.60

About Cumberland Pharmaceuticals

View Profile
Address
2525 West End Avenue
Nashville Tennessee 37203
United States
Employees -
Website http://www.cumberlandpharma.com
Updated 07/08/2019
Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of brands for the hospital acute care, gastroenterology, and oncology. Its product brands include acetadote, caldolor, kristalose, hepatoren, omeclamox, vaprisol, boxaban, vasculan, ethyol, portaban, and totect. The company was founded by A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.